Reactive Arthritis: When Infection Triggers Joint Pain

Most people expect joint pain to have an obvious cause — an injury, years of wear and tear, or a clearly identified inflammatory disease. However, sometimes joint pain appears from an entirely unexpected direction. An infection clears up. The person feels better. Then, days or weeks later, the joints start swelling and aching — seemingly out of nowhere.

Reactive arthritis is exactly this phenomenon. It is a form of inflammatory arthritis that develops as the immune system’s response to an infection elsewhere in the body. The infection itself is typically in the gut or the urogenital tract — and by the time joint symptoms appear, the original infection has often already resolved. The joints are not infected directly. Instead, the immune system triggers inflammation in them as a misguided side effect of fighting the original infection.

Reactive arthritis infection triggers joint pain is a pattern that affects people of all ages and both sexes. Furthermore, it is one of the most misunderstood and frequently delayed diagnoses in rheumatology — partly because the connection between an earlier infection and subsequent joint pain is not always obvious to patients or their doctors. Consequently, understanding the timeline, the symptoms, and the treatment options gives patients the best chance of getting the right diagnosis and care without unnecessary delay.

Quick Answer

Reactive arthritis is an inflammatory joint condition triggered by an immune response to a preceding infection — usually in the gut or urogenital tract. It causes swollen, painful joints — typically in the lower limbs — along with eye inflammation and urinary symptoms in some patients. Most cases resolve within months with anti-inflammatory treatment and targeted physiotherapy.

What Is Reactive Arthritis?

How It Differs From Infectious Arthritis

Reactive arthritis is fundamentally different from septic arthritis — the condition in which bacteria directly infect a joint. In septic arthritis, bacteria or other pathogens are physically present inside the joint space, directly causing damage and inflammation. In reactive arthritis, by contrast, no live organisms exist within the joints. Instead, the immune system — in the process of fighting an infection elsewhere in the body — produces an inflammatory response that spills over into the joints and other tissues.

This distinction is clinically important. It means that antibiotics — which are essential for treating septic arthritis — do not directly treat the joint inflammation in reactive arthritis. Furthermore, joint fluid analysis in reactive arthritis does not show bacteria on culture. Consequently, the diagnosis rests on recognising the clinical pattern and linking it to a preceding infection rather than finding evidence of active infection in the joint itself.

The Name Reiter’s Syndrome

Reactive arthritis has historically been called Reiter’s syndrome — named after a German physician who described the classic triad of arthritis, urethritis, and conjunctivitis in 1916. However, Reiter’s name carries significant historical controversy because of his documented involvement in unethical medical experiments during the Second World War. Consequently, most medical societies and journals now prefer the term reactive arthritis, which is more descriptive and avoids the eponymous association. Both terms appear in medical literature and patient resources.

What Causes Reactive Arthritis?

The Triggering Infections

Reactive arthritis infection triggers joint pain through a well-defined set of initiating infections. Two main categories of infection trigger the condition. The first is gastrointestinal infection — bacterial gastroenteritis caused by organisms including Salmonella, Shigella, Campylobacter, and Yersinia. These bacteria infect the gut, typically causing diarrhoea, abdominal cramps, and fever. Reactive arthritis develops in approximately 1 to 4% of people who contract these gastrointestinal infections.

The second major category is urogenital infection. Chlamydia trachomatis — a sexually transmitted bacterium — is the most common urogenital trigger of reactive arthritis in developed countries. Chlamydia infections in men often cause urethritis — inflammation of the urethra — with discharge and burning on urination. In women, however, Chlamydia infection frequently causes no symptoms at all. Consequently, the triggering urogenital infection goes unrecognised in a significant proportion of female patients, further delaying the link between infection and subsequent arthritis.

The Role of HLA-B27

Not everyone who contracts a triggering infection develops reactive arthritis. A significant genetic factor determines individual susceptibility. The HLA-B27 gene — a specific variant of a gene involved in immune recognition — is present in roughly 50 to 80% of patients with reactive arthritis. In the general population, HLA-B27 is present in only approximately 8% of people of northern European ancestry.

People who carry HLA-B27 face a substantially elevated risk of developing reactive arthritis after a triggering infection. Furthermore, those who carry HLA-B27 and develop reactive arthritis tend to have more severe disease and a higher risk of the condition becoming chronic. However, HLA-B27 is neither necessary nor sufficient to cause the disease — people without HLA-B27 can develop reactive arthritis, and many people with HLA-B27 never do. Consequently, HLA-B27 testing provides useful prognostic information but does not confirm or exclude the diagnosis on its own.

The Immune Mechanism

The precise mechanism by which an infection triggers joint inflammation in reactive arthritis remains incompletely understood. Current evidence suggests that bacterial antigens — fragments of the triggering bacteria — enter the bloodstream and travel to the joints, where they provoke an immune response. Furthermore, molecular mimicry may play a role — some bacterial proteins structurally resemble proteins found in joint tissue, causing the immune system to attack the joints while targeting the bacteria.

The synovium — the membrane lining the joint cavity — becomes inflamed as immune cells flood into the joint space. Consequently, the joint swells, becomes warm and painful, and produces excess synovial fluid. This inflammatory response can affect tendons, ligaments, and the sites where they attach to bone — a condition called enthesitis — as well as the eyes, skin, and mucous membranes in some patients.

Symptoms of Reactive Arthritis

Joint Symptoms

Reactive arthritis infection triggers joint pain in a characteristic pattern. The arthritis typically begins one to four weeks after the triggering infection resolves. It predominantly affects the large joints of the lower limbs — particularly the knees, ankles, and feet. Furthermore, it tends to be asymmetric — affecting different joints on different sides of the body, rather than affecting corresponding joints on both sides simultaneously as in rheumatoid arthritis.

The affected joints are swollen, warm, red, and painful. Movement increases the pain. In some patients, the entire digit swells to produce a sausage-shaped finger or toe — called dactylitis — a finding characteristic of reactive arthritis and other related spondyloarthropathies. Moreover, enthesitis — inflammation at the sites where tendons and ligaments attach to bone — produces pain at the heel, the sole of the foot, and around the pelvis. For context on how plantar fascia and heel enthesitis present and are managed, see our article on plantar fasciitis — why your heel hurts in the morning and how to fix it.

The Classic Triad

The classic triad of reactive arthritis combines joint inflammation with two additional features. Urethritis — inflammation of the urethra — produces burning on urination and discharge in men. In women, it may cause urinary frequency, discomfort, and cervicitis. Furthermore, conjunctivitis — inflammation of the lining of the eye — causes redness, discharge, and a gritty sensation in the eye in roughly 30% of patients. In some cases, a more serious eye inflammation called uveitis — affecting the inner structures of the eye — develops and requires urgent ophthalmological assessment to prevent permanent vision damage.

However, the complete classic triad of arthritis, urethritis, and conjunctivitis occurs in only a minority of patients. Many people develop only one or two of these features. Consequently, reactive arthritis should not be excluded as a diagnosis simply because all three components are not present.

Skin and Mucosal Features

Reactive arthritis also causes skin and mucosal changes in some patients. Keratoderma blennorrhagica — a skin rash of thickened, scaly patches resembling psoriasis — appears on the soles of the feet and palms in a small proportion of patients. Circinate balanitis — painless ulceration around the head of the penis — occurs in some male patients. Painless mouth ulcers and nail changes including thickening and separation from the nail bed are additional features.

These extra-articular features — the symptoms occurring outside the joints — reflect the systemic nature of the immune response driving reactive arthritis. They confirm that the condition affects multiple body systems simultaneously rather than the joints alone. Consequently, a thorough whole-body clinical assessment is essential for every patient with suspected reactive arthritis. For broader context on how autoimmune conditions produce multi-system effects, see our article on lupus nephritis — when lupus attacks the kidneys.

How Doctors Diagnose Reactive Arthritis

Clinical Assessment

Diagnosing reactive arthritis infection triggers joint pain begins with a careful clinical history. The key diagnostic step is establishing the temporal link between a preceding infection and the onset of joint symptoms. Doctors ask specifically about recent diarrhoeal illness, urinary symptoms, genital discharge, and sexual history. Furthermore, the pattern of joint involvement — asymmetric lower limb arthritis with enthesitis — is highly characteristic and guides diagnosis.

No single laboratory test confirms reactive arthritis. The diagnosis rests on clinical pattern recognition combined with supporting investigations. Consequently, doctors must maintain a high index of suspicion and actively ask about recent infections in any young adult presenting with acute inflammatory arthritis of the lower limbs.

Laboratory Investigations

Blood tests show markers of systemic inflammation. The erythrocyte sedimentation rate — ESR — and C-reactive protein — CRP — are typically elevated, confirming active inflammatory disease. A full blood count may show raised white blood cell count during active disease. Furthermore, HLA-B27 testing provides prognostic information about severity and chronicity risk, though it does not confirm the diagnosis.

Testing for the triggering infection is essential. Stool culture identifies Salmonella, Shigella, Campylobacter, and Yersinia in cases triggered by gastrointestinal infection. Urethral swab or urine nucleic acid amplification testing — called NAAT — detects Chlamydia trachomatis reliably. Sexual health screening for other urogenital pathogens is recommended for all patients with suspected urogenital trigger. Consequently, identifying the triggering organism guides antibiotic treatment of any residual infection and informs contact tracing when appropriate.

Imaging and Joint Fluid Analysis

Plain X-ray of affected joints is usually normal in early reactive arthritis because inflammatory arthritis takes weeks to months to produce visible bony changes. However, X-ray excludes other causes of acute joint pain — including fracture, crystal arthropathy, and established inflammatory arthritis with erosive changes.

Ultrasound and MRI detect early synovial inflammation, enthesitis, and periarticular soft tissue changes that X-ray misses entirely. Furthermore, they confirm the diagnosis and guide management when clinical findings are uncertain. Joint aspiration — withdrawing fluid from a swollen joint — provides fluid for analysis and culture. The fluid in reactive arthritis shows inflammatory cells without bacteria on culture, directly distinguishing reactive arthritis from septic arthritis. Consequently, joint aspiration is indicated whenever septic arthritis needs to be excluded — which it always does when a joint is acutely hot, swollen, and painful.

Treatment of Reactive Arthritis

Anti-Inflammatory Medications

Treatment of reactive arthritis infection triggers joint pain focuses on controlling inflammation, managing symptoms, and treating any residual infection. NSAIDs — non-steroidal anti-inflammatory drugs including ibuprofen, naproxen, and diclofenac — are the cornerstone of first-line treatment. They reduce joint pain and swelling effectively in the majority of patients.

NSAIDs should be taken at adequate doses for sufficient duration — typically four to six weeks — rather than intermittently. Furthermore, taking them with food reduces gastrointestinal side effects. However, NSAIDs carry kidney, cardiovascular, and gastrointestinal risks with prolonged use. Consequently, doctors review the need for ongoing NSAID therapy at each follow-up appointment and adjust dosing as symptoms respond. For context on how NSAIDs affect kidney function, see our article on chronic kidney disease — stages, symptoms, and how to slow the decline.

Corticosteroids and Joint Injections

When NSAIDs alone provide insufficient relief, corticosteroids — anti-inflammatory steroid medications — provide faster and more powerful symptom control. Doctors administer them either orally as a short course of prednisolone or through direct intra-articular injection into the most severely affected joints.

Intra-articular corticosteroid injection delivers high-dose anti-inflammatory medication directly into the inflamed joint. This produces significant local relief while minimising systemic steroid exposure. Moreover, it is particularly useful when one or two joints are disproportionately affected and limiting function. Consequently, joint injection is a valuable adjunct when systemic treatment alone leaves significant residual joint inflammation.

Antibiotics for Residual Infection

The role of antibiotics in reactive arthritis depends on whether active infection persists at the time of diagnosis. When Chlamydia trachomatis is identified as the trigger, antibiotic treatment — typically doxycycline or azithromycin — eradicates any residual infection and is strongly recommended. Furthermore, sexual contacts require notification and testing.

However, for gastrointestinal triggers, antibiotics do not shorten the course of reactive arthritis and are not routinely indicated once the acute gut infection has resolved. Moreover, evidence does not support prolonged antibiotic courses for the joint inflammation itself. Consequently, antibiotic prescribing in reactive arthritis is targeted to confirmed residual infection rather than used as a blanket treatment for the arthritis.

Disease-Modifying Drugs for Chronic Cases

Most patients with reactive arthritis recover fully within three to twelve months without long-term immunosuppressive treatment. However, roughly 15 to 20% of patients develop chronic reactive arthritis — persistent joint inflammation lasting more than twelve months. These patients require disease-modifying antirheumatic drugs — called DMARDs — to prevent ongoing joint damage.

Sulfasalazine is the most commonly used DMARD for chronic reactive arthritis. It reduces inflammation through mechanisms that differ from NSAIDs and steroids. Furthermore, methotrexate is used for patients who do not respond adequately to sulfasalazine. In severe chronic disease — particularly when enthesitis and spinal involvement predominate — biologic agents targeting tumour necrosis factor, called TNF inhibitors, produce significant benefit. Consequently, specialist rheumatology involvement is essential for all patients with chronic or severe reactive arthritis. For context on managing chronic inflammatory conditions requiring long-term specialist oversight, see our article on lupus nephritis — when lupus attacks the kidneys.

Physiotherapy and Rehabilitation

Physiotherapy plays an important role throughout reactive arthritis management. During the acute phase, gentle joint movement within pain limits prevents stiffness and maintains joint nutrition. After the acute inflammation subsides, progressive strengthening exercises restore muscle support around the affected joints.

Enthesitis at the heel and sole of the foot — a common feature of reactive arthritis — responds well to calf stretching, orthotic support, and physiotherapy-guided loading programmes. Furthermore, education about the condition — its typical self-limiting course, the importance of activity modification, and the role of exercise in recovery — significantly improves patient confidence and adherence to treatment. Consequently, physiotherapy is most effective when integrated with medical treatment rather than offered as a standalone intervention. For context on how enthesitis-related heel pain is managed, see our article on plantar fasciitis — why your heel hurts in the morning and how to fix it.

Long-Term Outlook and Monitoring

Recovery and Recurrence

The prognosis for reactive arthritis is generally favourable. Roughly 80 to 85% of patients achieve full remission within three to twelve months with appropriate treatment. However, recurrence is possible — particularly if the patient contracts another triggering infection. Furthermore, patients who carry HLA-B27 face a higher recurrence risk than those without the gene variant.

A small proportion of patients — particularly those with persistent enthesitis and spinal involvement — eventually develop ankylosing spondylitis — a chronic inflammatory spinal condition. Consequently, regular rheumatology review during the first two years after diagnosis identifies the small subgroup of patients whose disease is transitioning to a chronic spondyloarthropathy requiring more intensive long-term management.

Eye and Systemic Monitoring

Eye involvement in reactive arthritis requires careful monitoring. Conjunctivitis typically resolves without specific treatment. However, uveitis — inflammation of the inner eye — can damage the retina and iris if untreated. Consequently, any patient with reactive arthritis who develops eye pain, redness, photosensitivity, or visual disturbance needs urgent ophthalmology assessment.

Furthermore, patients with reactive arthritis face an elevated long-term cardiovascular risk — shared with other inflammatory arthritis conditions — through the mechanisms of chronic systemic inflammation. Consequently, cardiovascular risk factor management forms an important component of long-term follow-up for patients whose disease becomes chronic. For context on how chronic musculoskeletal inflammation affects overall health, see our articles on osteoarthritis — inflammation, causes, and what actually helps — and fibromyalgia — the pain condition that is real, widely misunderstood, and treatable.

When to Seek Urgent Medical Help

Seek emergency care immediately if a joint becomes acutely hot, severely swollen, and exquisitely tender — particularly with fever and feeling systemically unwell. These features may indicate septic arthritis — a joint infection requiring emergency joint drainage and intravenous antibiotics. Reactive arthritis does not cause this level of systemic illness.

Furthermore, seek urgent ophthalmology assessment if eye pain, significant redness, or visual disturbance develop in a patient with known or suspected reactive arthritis. Uveitis requires prompt treatment to prevent permanent eye damage. Consequently, patients and their families should have a clear plan for recognising and responding to these warning signs without delay.

Frequently Asked Questions

1. How long does reactive arthritis last?

Most cases of reactive arthritis resolve within three to twelve months with appropriate treatment. Roughly 80 to 85% of patients achieve full remission within this timeframe. However, approximately 15 to 20% of patients develop chronic reactive arthritis lasting more than twelve months and requiring long-term disease-modifying treatment. Furthermore, recurrence after a subsequent triggering infection is possible in recovered patients. Consequently, follow-up after initial recovery is important to catch early signs of relapse or chronic disease development.

2. Can reactive arthritis be prevented?

There is no reliable way to prevent reactive arthritis entirely in susceptible individuals. However, reducing exposure to triggering infections lowers the risk significantly. Safe sexual practices and Chlamydia screening reduce the risk of urogenital triggers. Good food hygiene and safe drinking water reduce gastrointestinal infection risk. Furthermore, prompt antibiotic treatment of confirmed Chlamydia infection may reduce the risk of reactive arthritis developing after urogenital infection. Consequently, general infection prevention measures provide the most practical available protection.

3. Is reactive arthritis contagious?

Reactive arthritis itself is not contagious. The joint inflammation does not spread from person to person. However, when Chlamydia trachomatis triggers the reactive arthritis, the original Chlamydia infection is sexually transmissible. Furthermore, the gastrointestinal bacteria that trigger reactive arthritis — including Salmonella, Shigella, and Campylobacter — spread through contaminated food and water. Consequently, sexual contacts of patients with Chlamydia-triggered reactive arthritis require testing and treatment, and food safety guidance is relevant for gastrointestinally triggered cases.

4. How does reactive arthritis differ from rheumatoid arthritis?

Reactive arthritis and rheumatoid arthritis are both inflammatory joint conditions but differ in several important ways. Reactive arthritis follows a known triggering infection and predominantly affects asymmetric lower limb joints. Rheumatoid arthritis has no infectious trigger, affects small joints symmetrically — particularly the hands and wrists — and is driven by autoantibodies including rheumatoid factor and anti-CCP antibodies. Furthermore, reactive arthritis is typically self-limiting while rheumatoid arthritis is a lifelong condition requiring indefinite treatment. Consequently, accurate diagnosis of which inflammatory arthritis is present is essential before treatment begins.

5. Can children develop reactive arthritis?

Yes. Children can develop reactive arthritis — though it is less common than in adults. In children, gastrointestinal infections — particularly those caused by Salmonella and Campylobacter — are the most common triggers. Furthermore, reactive arthritis in children can be confused with juvenile idiopathic arthritis — a chronic childhood inflammatory joint condition — particularly when the link to the preceding infection is not recognised. Consequently, a careful infection history in any child presenting with acute inflammatory joint disease is essential for establishing the correct diagnosis and avoiding unnecessary long-term immunosuppressive treatment.

Conclusion

Reactive arthritis is a condition that catches both patients and doctors by surprise. A gut infection clears up. A urinary infection resolves. Then, weeks later, joints swell and ache in ways that seem completely disconnected from the original illness. Understanding this connection — and acting on it promptly — is the key to faster diagnosis and better outcomes.

Reactive arthritis infection triggers joint pain through a well-understood immunological mechanism that responds well to targeted anti-inflammatory treatment in the vast majority of patients. Furthermore, most people recover fully within twelve months and return to their normal lives without lasting joint damage. However, early recognition, accurate diagnosis, and appropriate management of both the joint inflammation and the triggering infection all make a meaningful difference to the speed and completeness of recovery.

If you develop swollen, painful joints in the weeks following a gut infection, urinary symptoms, or any illness that might have an infectious cause, speak to a doctor without delay. Consequently, establishing the diagnosis early — before the inflammatory process damages joint tissue — gives reactive arthritis the best possible chance of resolving completely and permanently.

References

1. .Ankylosing spondylitis is a chronic autoimmune inflammatory arthritis primarily affecting the spine and sacroiliac joints. 
2. Wellington Regional Hospital has changed its approach to infection surveillance in the NICU. Rather than waiting for infants to fall ill
3. During the campaign, Aditya proposed installing water coolers on every floor of the school building. Students loved the idea, praising it as practical and student-focused. 

Disclaimer

This article adapts publicly available information from WHO’s Musculoskeletal Conditions page. This content is for informational and educational purposes only and does not constitute medical advice. ObserverVoice.com is a news and information platform and not a healthcare provider.